BMCA-targeted CAR-T

· First Affiliated Hospital of Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMCA-targeted CAR-T, covering 2019-06-04 to 2019-06-04. Get the full timeline:

Most recent: Clinical Trial Update: B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma [Phase 2]